Other than the original quoted article from Bioworld and Recce announcing that it is targeting the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) global initiative, which is offering a $1 billion reward for each new antibiotic approved, as well as increased R&D funding, I found the following articles and websites that mention these sort of rewards, there is also the Billions of potential revenue for any company that gets a new superbug antibiotic approved.
https://www.washingtonpost.com/opin...ory.html?noredirect=on&utm_term=.d5077c74e22e
http://www.ip-watch.org/2018/02/15/...d-2018-seeks-partners-antibacterial-research/
http://www.cidrap.umn.edu/news-perspective/2018/01/1-billion-reward-proposed-new-antibiotics
https://www.nature.com/articles/ja2017124
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746591/
- Forums
- ASX - By Stock
- RCE
- Accelerated Approval for RECCE® 327
Accelerated Approval for RECCE® 327, page-27
-
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
|
|||||
Last
49.0¢ |
Change
0.030(6.52%) |
Mkt cap ! $108.6M |
Open | High | Low | Value | Volume |
46.5¢ | 49.5¢ | 46.5¢ | $155.2K | 322.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 536 | 48.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
49.0¢ | 22195 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 555 | 0.485 |
1 | 15073 | 0.475 |
3 | 91631 | 0.470 |
3 | 35670 | 0.465 |
2 | 30417 | 0.460 |
Price($) | Vol. | No. |
---|---|---|
0.490 | 22222 | 1 |
0.495 | 90636 | 1 |
0.500 | 1000 | 1 |
0.510 | 100000 | 1 |
0.540 | 158 | 1 |
Last trade - 14.47pm 06/08/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |